SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

CleanSpark is drawing attention after a steep selloff that traders say has outpaced Bitcoins decline, amid weakness across bitcoin miners and concerns about the companys financing and execution. Bulls point to its Meta-linked data-center lease and Bitcoin holdings as long-term value, while bears expect further downside and question why the stock is falling despite Bitcoin holding up.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereums uneven price action and repeated tests of support are driving discussion, with traders debating whether the pullback will deepen or give way to a rebound. Bearish posts cite weak momentum and failed resistance, while bulls point to dip buying, accumulation, and institutional use of Ethereums network.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Novartis/Aviditys failed Phase 3 DM1 trial has prompted concern about whether DMPK knockdown can translate into functional benefit, weighing on Sarepta by association. Traders disagree on how much that result applies to Sareptas distinct siRNA approach, with upcoming DM1 and FSHD data viewed as the key test of the pipeline.

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpools weak quarterly results and sharply reduced outlook, coupled with its suspension of the common dividend to prioritize debt reduction, are driving attention as shares sell off. The community is split between fears of further financial distress and bargain hunters anticipating a rebound, while many criticize managements attribution of weak appliance demand to the Iran conflict.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Globals long-term LNG supply agreements, including the 20-year ConocoPhillips deal and a reported China Gas contract, are drawing attention as traders weigh the added customer validation and contracted-volume visibility. Some see the agreements as positive, while others argue that long-dated contracts may limit upside from spot-price spikes and point to debt, arbitration and execution risks.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Discussion centers on Aerodromes planned AerodromeVelodrome merger and multichain expansion, which bulls see as a way to broaden liquidity and revenue while improving token value capture. Others worry about added supply, emissions, delays, and a possible sell-the-news reaction, amid volatile price action.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRPs continued pullback and weak performance near key support levels dominate the discussion, with traders debating whether it reflects broader crypto-market pressure or XRP-specific concerns about token supply, Ripples escrow releases, and whether adoption translates into demand for the token. Bears question its utility and see further downside risk, while bulls are buying the dip and pointing to support and upcoming adoption catalysts.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visas upcoming full-year earnings report is the main focus, with traders positioning around the results as the stock trades near record highs. The community is split between bullish momentum and confidence in the business, and concerns that the shares are overbought or vulnerable to a pullback.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Aetnas weaker Medicare Advantage star ratings are drawing attention, with traders concerned about lost quality bonuses and pressure on CVSs insurance margins. Some argue the setback may already be priced in or expect a recovery, while others emphasize the ratings as a meaningful headwind.

dogwifhat (WIF) is a Solana-based memecoin featuring a Shiba Inu dog wearing a pink knitted hat that has become a central figure in the 2024-2026 market. Originally launched anonymously in late 2023, the project operates on a decentralized, community-driven model with no formal venture capital backing or complex tokenomics. It represents a cultural phenomenon on the Solana blockchain that celebrates whimsy and simplicity over technical complexity, focusing on its identity as a playful mascot for the digital finance era. The project’s main value proposition is its "Pure Meme Identity," as it maintains a strict focus on its meme origins without forced utility or a pivot toward DeFi and gaming.  The project embodies the community-driven nature of the Solana ecosystem, prioritizing "vibes" and meme-sharing as its primary growth drivers. It follows a "hat stays on" philosophy, maintaining a singular focus on its core meme rather than building a complex ecosystem. While the project does not have a formal governance structure or DAO, decisions are largely driven by social consensus among the community and key influencers. Notable community initiatives include the "Sphere Wif Hat" campaign, which raised nearly $700,000 in USDC in March 2024 to put the mascot on the Las Vegas Sphere. However, after a year of negotiations and delays, organizers officially abandoned the advertisement on March 31, 2025, and initiated a full refund process for donors.  The initial team behind dogwifhat remains anonymous, which is a standard practice within the memecoin sector. The coin's narrative is heavily influenced by prominent crypto personalities, most notably Ansem, who was a key figure in the project's early viral growth and subsequent marketing initiatives. Regarding integrations, WIF has deep liquidity across major Solana decentralized exchanges like Jupiter and Raydium, is available on the Unichain network via official contract bridging, and is listed on major centralized exchanges including Binance, Coinbase, Kraken, and Bybit.  WIF is a purely speculative asset whose value is primarily driven by community sentiment and meme culture rather than traditional utility. It was launched without a presale or significant venture capital allocation, meaning the token's supply is fully circulating. The project has achieved a "blue chip" status in the memecoin space, often serving as a beta-play for the broader health of the Solana ecosystem. No native decentralized applications or trading bots have been officially launched by the core team, as the project maintains its focus on its identity as "literally a dog wif a hat".

dogwifhat

WIF is drawing attention for persistent selling and prolonged, largely flat-to-red trading, with many holders expressing frustration and alleging price manipulation. A smaller bullish contingent views the weakness as an accumulation opportunity and hopes for a rebound alongside a broader crypto or meme-coin rally.

statis crypto Watchlist

Bitcoin

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Attention centers on new ESMO data for gedatolisib: updated Phase 3 VIKTORIA-1 breast-cancer results drew praise, alongside early prostate-cancer results that traders see as a possible second-market opportunity. The community is weighing the encouraging findings against the small, uncontrolled prostate study and questioning why the shares remain weak despite the clinical news and the drugs commercial launch.

New Strong Sell Stocks for October 14th

ADDYY, CELC and CNL have been added to the Zacks Rank #5 (Strong Sell) List on October 14, 2026.

Why Celcuity Stock Was a Winner on Wednesday

Key PointsThis is a breast cancer treatment, Revtorpyk...

Shredding Pounds, Trading Stocks—Lilly’s Potential Obesity Blockbuster and other Biotechs in Play

The biotech tape is entering a catalyst-heavy stretch, with NeOnc Technologies Holdings (NASDAQ:NTHI), Connect Biopharma (NASDAQ:CNTB), Valion Bio (NASDAQ:VBIO), Eli Lilly and Company (NYSE:LLY), Celcuity (NASDAQ:CELC), and Capricor Therapeutics (NASDAQ:CAPR) heading into important stretches, but for very different reasons.

Celcuity Analysts Slash Their Forecasts After Q2 Loss

Celcuity Inc (NASDAQ:CELC) reported better-than-expected Q2 losses of $1.07 per share. Analysts are optimistic with price target cuts by Needham and Stifel.read more...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celcuity Inc. - CELC

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celcuity Inc. - CELC INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celcuity Inc. - CELC PR Newswire NEW YORK, Aug. 6, 2026 NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP is...

CELC SHAREHOLDER ALERT: Celcuity Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Celcuity Inc. (Celcuity or the Company) (NASDAQ: CELC) investors concerning the Companys and/or members of its senior managements possible violation of the federal securities laws or other unlawful business...

CELC Investors Have Opportunity to Join Celcuity Inc. Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Celcuity Inc. (Celcuity or the Company) (NASDAQ: CELC) for violations of the securities laws.INVESTIGATION DETAILS: The investigation focuses on...

CELC Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Celcuity Inc. (NASDAQ: CELC) Investors to Contact the Firm

CELC Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Celcuity Inc. (NASDAQ: CELC) Investors to Contact the Firm CELC Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Celcuity Inc. (NASDAQ: CELC) Investors to Contact the Firm PR Newswire RADNOR, Pa., July 31, 2026 RADNOR...

INVESTOR ALERT: Pomerantz Law Firm Investigates ClaimsnOn Behalf of Investors of Celcuity Inc. - CELC

INVESTOR ALERT: Pomerantz Law Firm Investigates ClaimsnOn Behalf of Investors of Celcuity Inc. - CELC INVESTOR ALERT: Pomerantz Law Firm Investigates ClaimsnOn Behalf of Investors of Celcuity Inc. - CELC PR Newswire NEW YORK, July 30, 2026 NEW YORK, July 30, 2026 /PRNewswire/ -- Pomerantz LLP is...

NASDAQ: CELC Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Celcuity Inc. (NASDAQ: CELC) Investors to Contact the Firm

Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Celcuity Inc. (NASDAQ: CELC) on behalf of investors who purchased or acquired Celcuity Inc. securities and experienced...

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

CELC Stock Clocks Best Day In About 2 Months On First FDA Approval For Cancer Drug

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>The FDA approved gedatolisib in combination with cancer drug fulvestrant, with or without Pfizer’s palbociclib.</li><li>This approval gives the company its first marketed product and transitions it from a pure development-stage firm to one with a commercial opportunity.</li><li>Celcuity’s pipeline remains centered on gedatolisib, with ongoing work in earlier lines of breast cancer and prostate cancer.</li></ul> Shares of Celcuity Inc. (CELC) jumped 7% on Tuesday after the U.S. Food and Drug Administration approved its drug gedatolisib in combination with cancer drug fulvestrant, with or without Pfizer’s palbociclib.The approval covers adults with advanced hormone receptor-positive, HER2-negative breast cancer without a PIK3CA mutation whose disease progressed after prior hormone therapy.The stock on Tuesday clocked its best day since May.<h2 class="st-heading-2">CELC's Trial Results</h2>The decision is based on the late-stage VIKTORIA-1 trial. The three-drug combination (gedatolisib + palbociclib + fulvestrant) cut the risk of disease progression or death by 76% and extended median progression-free survival to 9.3 months, compared with just two months on fulvestrant alone.The two-drug combination (gedatolisib + fulvestrant) reduced risk by 67%, with a median PFS of 7.4 months. Response rates were also significantly higher with both gedatolisib regimens.Progression-Free Survival (PFS) is the length of time during and after treatment that a patient lives with a disease, like cancer, without it getting worse. It measures how long a therapy successfully keeps the tumor from growing, spreading, or returning.Gedatolisib is given as a weekly intravenous infusion. The company intends to launch the drug commercially in the third quarter.<h2 class="st-heading-2">Company Pipeline And Impact</h2>Gedatolisib, in-licensed from Pfizer in 2021, is Celcuity’s sole late-stage asset and has been the focus of its entire development program.This approval gives the company its first marketed product and transitions it from a pure development-stage firm to one with a commercial opportunity in advanced breast cancer. Celcuity’s pipeline remains centered on gedatolisib, with ongoing work in earlier lines of breast cancer and prostate cancer.Celcuity had cash, cash equivalents, and short-term investments of $387.1 million as of the end of last quarter. Celcuity then said its current cash position, together with its debt facility, is expected to fund operations through 2027.<h2 class="st-heading-2">How Did CELC Retail Traders React?</h2>On Stocktwits, retail sentiment around CELC stock stayed within the bullish territory over the past 24 hours, while message volume stayed at extremely high levels.A Stocktwits user opined that the stock should have rallied further on “such a big news.”<stembedurl>https://www.stocktwits.com/bullwink/message/659051202</stembedurl>Another user voiced hopes for a buyout of the company.<stembedurl>https://www.stocktwits.com/LarInvests/message/659050394</stembedurl>A third user termed the stock a “huge opportunity” under $115.<stembedurl>https://www.stocktwits.com/kellymone2/message/659049854</stembedurl>According to data from Koyfin, all 12 analysts covering CELC stock rate it ‘Buy’ or higher. The stock has a 12-month average price target of $160.64, representing a potential upside of about 45% from its last close.<a href="https://stocktwits.com/symbol/CELC">CELC stock</a> has gained 11% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/lcid-stock-tumbles-on-bankruptcy-rumors-lucid-says-reports-are-completely-false/cZZR42GR7qo">LCID Stock Tumbles On Bankruptcy Rumors — Lucid Says Reports Are ‘Completely False’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Celcuity logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Gedatolisib, in-licensed from Pfizer in 2021, is Celcuity’s sole late-stage asset.

Vanguard Total Stock Market ETF

SPDR S&P Biotech ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$65.25
Prev Close	$65.57
Open	$65.57
Dividend Yield	0.00%
50-Day Moving Average	$80.07
Beta	1.19
Avg. Volume	974,262.14
PE Ratio	-15.18

52-Week High	$151.02
52-Week Low	$53.54
Market Capitalization	$3.19B
EPS (Annual)	-$3.79
Price to Book	-249.76
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

CELC Fundamentals